4//SEC Filing
McClure Matthew W. 4
Accession 0001567619-23-005257
CIK 0001799448other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:12 PM ET
Size
5.7 KB
Accession
0001567619-23-005257
Insider Transaction Report
Form 4
McClure Matthew W.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-15+75,000→ 75,000 totalExercise: $1.34Exp: 2033-03-15→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 15, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001927121
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:12 PM ET
- Size
- 5.7 KB